Core Viewpoint - The establishment of Shanghai Weinao Intelligent Technology Co., Ltd. marks a significant step in the strategic deployment of Xinwei Medical in the brain-computer interface (BCI) sector, transitioning from planning to practical implementation [1][2] Group 1: Company Developments - Xinwei Medical's subsidiary, Weinao Intelligent, has completed its business registration and is now located in the Shanghai Brain-Computer Interface Future Industry Cluster [1] - The company aims to focus on the research and clinical application of BCI technology, facilitating the transition from basic research to clinical treatment [1][2] - The establishment of Weinao Intelligent signifies a new phase of independent and specialized operations for Xinwei Medical in the BCI business [2] Group 2: Technological Innovations - The BCI project submitted by Xinwei Medical utilizes an innovative minimally invasive approach, implanting electrode stents into brain blood vessels without the need for craniotomy, significantly reducing surgical trauma [2] - This new method effectively avoids complications associated with traditional invasive surgeries, such as intracranial infections and long-term rejection reactions [2] - The intravascular electrodes can closely adhere to blood vessel walls, achieving a balance between high-quality neural signal acquisition and long-term stability [2] Group 3: Strategic Initiatives - Xinwei Medical's BCI project was selected for the 2025 Artificial Intelligence Medical Device Innovation Task, highlighting its strong innovation capabilities and potential for technology transfer [1] - The initiative aims to promote breakthroughs in AI medical devices and facilitate the practical application of products, with 16 BCI projects being selected [1]
心玮医疗成立脑机接口子公司 介入式脑机接口项目入选国家级“揭榜挂帅”名单